Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Met signaling mutants as tools for developmental studies.

C Ponzetto1, G Panté, C Prunotto'

  • 1Dept. of Anatomy, Pharmacology and Forensic Medicine, University of Turin, Italy. carola.ponzetto@unito.it

The International Journal of Developmental Biology
|November 4, 2000
PubMed
Summary

Investigating the Met receptor

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stem cells to restore insulin production and cure diabetes.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
Same author

Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation.

The international journal of neuropsychopharmacology·2014
Same author

MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Cellular and molecular life sciences : CMLS·2013
Same author

Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.

Oncogene·2013
Same author

Abl interconnects oncogenic Met and p53 core pathways in cancer cells.

Cell death and differentiation·2011
Same author

Enhanced neuronal Met signalling levels in ALS mice delay disease onset.

Cell death & disease·2011

Area of Science:

  • Developmental Biology
  • Cell Signaling
  • Molecular Biology

Background:

  • The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), are crucial for embryonic development.
  • Previous studies using null mutants highlighted their roles in placenta, liver, and limb muscle development.
  • Early lethality in null mutants limited the analysis of Met's function in later developmental stages.

Purpose of the Study:

  • To investigate the role of Met signaling in late embryonic development by creating hypomorphic Met alleles.
  • To dissect the specific contributions of Met kinase activity versus downstream signaling interactions.
  • To elucidate novel functions of the HGF/SF-Met pathway in muscle development.

Main Methods:

  • Generation of mice with mutated Met alleles affecting the docking site in the C-terminal tail.
  • Analysis of Met receptor kinase activity and effector recruitment in mutant mice.
  • Phenotypic analysis of mutant mice with varying degrees of Met signaling impairment.

Main Results:

  • Mice with a Met mutant retaining kinase activity but lacking effector recruitment died mid-gestation, confirming the necessity of phosphotyrosine-SH2 interactions.
  • Mice with partial loss of Met signaling function survived until birth.
  • These viable mutants revealed previously unknown roles for HGF/SF-Met signaling in muscle development.

Conclusions:

  • Phosphotyrosine-SH2 interactions mediated by the Met receptor are essential for embryonic development.
  • Partial impairment of Met signaling allows for survival and provides insights into its roles in later development, particularly in muscle formation.
  • The study successfully overcomes the limitations of early lethality to explore Met function in late development.

Related Experiment Videos